NTLA

Intellia Therapeutics, Inc.

Halal Rating :
Uncomfortable
See Details
Last Price $23.59 Last updated:
Market Cap $2.11b
7D Change 13.63%
1 Year Change -45.96%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 29, 2024

Intellia Therapeutics, Inc., a genome editing company, is focused on developing therapies. The company is headquartered in Cambridge, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $-1917000.0 $175.87m $12.46m $8.83m 649.92% 5.02%
Sept. 30, 2023 $12.99m $172.5m $12.74m - 98.06% 0.00%
June 30, 2023 $16.39m $176.58m $12.65m - 77.18% 0.00%

Company Impact

Help us evaluate Intellia Therapeutics, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates